Gilead Sciences Inc. closed 10.06% short of its 52-week high of $119.96, which the company achieved on March 10th.

The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

Elisabeth Moss is leading a rebellion in the sixth and final season "The Handmaid's Tale," which arrives on Hulu April 8.

The Handmaid's Tale is going out on a high note with a trailer teasing the deadly rebellion - and offering hints at the ...

NORTHAMPTON, MA / ACCESS Newswire / March 25, 2025 / HIV infection and lung cancer have little in common from a disease ...

Nvidia stock rises after the chip maker makes a number of product announcements at its annual AI GTC conference, and Tesla ...

It’s been a long minute since we’ve spent time in the hellscape of Gilead with The Handmaid’s Tale. Season five wrapped up in ...

Rowan Blanchard has officially joined the cast of The Testaments, Hulu's upcoming continuation of The Handmaid's Tale universe, according to Deadline.

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...

The series, based on the Margaret Atwood novel of the same name, is set 15 years after the events of “The Handmaid’s Tale.” ...

Hulu‘s The Handmaid’s Tale sequel series The Testaments has added Mattea Conforti (The Many Saints of Newark, Power) to its ...